Intensified Antiplatelet Treatment Reduces Major Cardiac Events in Patients with Clopidogrel Low Response: A Meta-analysis of Randomized Controlled Trials
Background: Clopidogrel low response (CLR) is an independent risk factor of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI), and intensified antiplatelet treatments (IAT) guided by platelet function assays might overcome laboratory CLR. However, whether IAT improves...
Main Authors: | Lei Xu, Xiao-Wei Hu, Shu-Hua Zhang, Ji-Min Li, Hui Zhu, Ke Xu, Jun Chen, Chun-Jian Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2016-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=8;spage=984;epage=991;aulast=Xu |
Similar Items
-
The effectiveness, side effects and acceptability of locally available brand of Clopidogrel (Osvix) as antiplatelet tablet in CABG patients
by: Behzad Imani, et al.
Published: (2014-07-01) -
Is Preoperative Clopidogrel Resistance a Predictor of Bleeding and Risks in Patients Undergoing Emergency CABG Surgery?
by: Mehmet Kizilay, et al. -
Efficacy of antiplatelet therapy for treating lacunar infarct: Meta-analysis
by: Da XU, et al.
Published: (2017-03-01) -
Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review
by: Carol Gravinese, et al.
Published: (2017-08-01) -
Resistência ao clopidogrel: prevalência e variáveis associadas
by: Fabrício Braga da Silva, et al.